FDA Inspection 946866 — Tomasz Zielinski, MD, PhD

Tomasz Zielinski, MD, PhD — FEI 3009540948

The FDA completed an inspection of Tomasz Zielinski, MD, PhD on October 9, 2015 in Katowice. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 9, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Katowice (Poland)

Additional Details

Clinical Investigator (CI)